VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,416,716 | -14.6% | 238,451 | -4.4% | 1.01% | +23.1% |
| Q2 2023 | $7,513,709 | -5.1% | 249,542 | +1.9% | 0.82% | -22.2% |
| Q1 2023 | $7,921,285 | +14.9% | 244,862 | +1.8% | 1.06% | +11.5% |
| Q4 2022 | $6,895,939 | +35.1% | 240,612 | +13.7% | 0.95% | +16.6% |
| Q3 2022 | $5,103,000 | +1.1% | 211,586 | +14.7% | 0.81% | +14.3% |
| Q2 2022 | $5,049,000 | +15.1% | 184,414 | +61.3% | 0.71% | +30.6% |
| Q1 2022 | $4,385,000 | +28.7% | 114,349 | +7.5% | 0.54% | +18.2% |
| Q4 2021 | $3,408,000 | +0.8% | 106,409 | -7.2% | 0.46% | -4.4% |
| Q3 2021 | $3,380,000 | -9.2% | 114,698 | +4.7% | 0.48% | -6.9% |
| Q2 2021 | $3,721,000 | +21.0% | 109,503 | +15.8% | 0.52% | +6.8% |
| Q1 2021 | $3,074,000 | -25.4% | 94,598 | -17.4% | 0.48% | -32.3% |
| Q4 2020 | $4,123,000 | +27.7% | 114,463 | +38.8% | 0.72% | +8.5% |
| Q3 2020 | $3,229,000 | +11.3% | 82,454 | +4.3% | 0.66% | +3.1% |
| Q2 2020 | $2,900,000 | +104.5% | 79,070 | +28.5% | 0.64% | +100.6% |
| Q1 2020 | $1,418,000 | -18.6% | 61,550 | +3.4% | 0.32% | +11.5% |
| Q4 2019 | $1,743,000 | +42.8% | 59,525 | +30.2% | 0.29% | +20.7% |
| Q3 2019 | $1,221,000 | +16.5% | 45,715 | +11.5% | 0.24% | +14.5% |
| Q2 2019 | $1,048,000 | +15.9% | 40,988 | +1.7% | 0.21% | +191.5% |
| Q1 2019 | $904,000 | +13.7% | 40,304 | +6.9% | 0.07% | -48.6% |
| Q4 2018 | $795,000 | +7.0% | 37,694 | -6.0% | 0.14% | +7.8% |
| Q3 2018 | $743,000 | -17.0% | 40,094 | 0.0% | 0.13% | -24.7% |
| Q2 2018 | $895,000 | 0.0% | 40,094 | -1.5% | 0.17% | +4.3% |
| Q1 2018 | $895,000 | -5.1% | 40,719 | +0.4% | 0.16% | -5.2% |
| Q4 2017 | $943,000 | +0.2% | 40,569 | -1.0% | 0.17% | -2.3% |
| Q3 2017 | $941,000 | -0.8% | 40,969 | -4.7% | 0.18% | +17.3% |
| Q2 2017 | $949,000 | +2.2% | 42,969 | +5.5% | 0.15% | -17.6% |
| Q1 2017 | $929,000 | +9.0% | 40,719 | 0.0% | 0.18% | +139.5% |
| Q4 2016 | $852,000 | -35.1% | 40,719 | -18.1% | 0.08% | -66.1% |
| Q3 2016 | $1,313,000 | -15.6% | 49,694 | -11.5% | 0.22% | -34.5% |
| Q2 2016 | $1,556,000 | – | 56,137 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |